UroGen Pharma Ltd. (URGN)

UroGen Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	90.04	171.99	95	55.41	44.36	52.86
Short-Term Investments	36.99	64.7	41.97	44.56	44.78	49.15
Cash & Short-Term Investments	127.03	236.69	136.97	99.96	89.14	102.02
Cash Growth	-49.10%	72.80%	37.02%	12.14%	-12.62%	-30.64%
Receivables	19.7	20.3	15.44	12.7	11.72	7.05
Inventory	8.34	9.23	5.67	4.33	4.83	1.96
Prepaid Expenses	12.12	8.85	10.28	11.1	7.48	3.36
Restricted Cash	1.35	1.08	0.82	0.81	1.23	1.23
Total Current Assets	168.55	276.14	169.19	128.91	114.39	115.62
Property, Plant & Equipment	9.18	3.79	2.36	3.75	3.15	4.2
Long-Term Investments	0.38	5.02	4.5	-	0.68	1.89
Other Long-Term Assets	6.94	0.77	2.26	2.96	1.53	0.29
Total Assets	185.05	285.71	178.31	135.62	119.75	122.01
Accounts Payable	10.28	10.93	6.51	5.53	5.79	3.27
Accrued Expenses	27.01	27.07	20.84	15.11	13.26	16.31
Current Portion of Leases	1.59	1.53	0.82	0.94	1.09	1.2
Other Current Liabilities	3.37	6.42	3.04	2.34	2.24	0.66
Total Current Liabilities	42.24	45.95	31.21	23.92	22.38	21.44
Long-Term Debt	122.11	121.73	98.55	97.54	-	-
Long-Term Leases	6.24	1.65	0.84	1.59	0.4	1.5
Other Long-Term Liabilities	129.86	125.18	112.92	101.94	88.56	2.72
Total Liabilities	300.45	294.51	243.52	224.98	111.33	25.65
Common Stock	0.13	0.12	0.09	0.06	0.06	0.06
Additional Paid-In Capital	817.79	797.25	614.04	487.79	475.7	452.53
Retained Earnings	-933.35	-806.22	-679.35	-577.1	-467.32	-356.5
Comprehensive Income & Other	0.02	0.06	0.01	-0.11	-0.03	0.27
Total Common Equity	-115.41	-8.8	-65.21	-89.36	8.41	96.36
Shareholders' Equity	-115.41	-8.8	-65.21	-89.36	8.41	96.36
Total Liabilities & Equity	185.05	285.71	178.31	135.62	119.75	122.01
Total Debt	129.94	124.92	100.21	100.06	1.49	2.7
Net Cash (Debt)	-2.53	116.79	41.26	-0.1	88.33	101.21
Net Cash Growth	-	183.09%	-	-	-12.73%	-47.13%
Net Cash Per Share	-0.05	2.72	1.43	-0.00	3.95	4.65
Filing Date Shares Outstanding	46.81	46.09	34.12	23.44	22.67	22.27
Total Common Shares Outstanding	46.78	42.23	32.49	23.13	22.46	22.17
Working Capital	126.3	230.19	137.97	104.99	92.01	94.18
Book Value Per Share	-2.47	-0.21	-2.01	-3.86	0.37	4.35
Tangible Book Value	-115.41	-8.8	-65.21	-89.36	8.41	96.36
Tangible Book Value Per Share	-2.47	-0.21	-2.01	-3.86	0.37	4.35
Machinery	4.58	4.31	4.02	3.83	3.58	2.83
Leasehold Improvements	0.63	0.63	0.62	0.62	0.62	0.61

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q